197214 Impact of co-location of substance abuse and chronic disease treatment

Monday, November 9, 2009: 2:48 PM

Carlota John-Hull, MD , Division of Medical Services, Research and Information Technology, Addiction Research and Treatment Corporation, Brooklyn, NY
Steven Kritz, MD , Division of Medical Services, Research and Information Technology, Addiction Research and Treatment Corporation, Brooklyn, NY
Melissa Chu, MS , Division of Medical Services, Research and Information Technology, Addiction Research and Treatment Corporation, Brooklyn, NY
Charles Madray, RPA-C, MBA , Division of Medical Services, Research and Information Technology, Addiction Research and Treatment Corporation, Brooklyn, NY
Roberto Zavala, MD , Division of Medical Services, Research and Information Technology, Addiction Research and Treatment Corporation, Brooklyn, NY
Lawrence S. Brown, MD, MPH, FASAM , Division of Medical Services, Research and Information Technology, Addiction Research and Treatment Corporation, Brooklyn, NY
Issues: The Addiction Research and Treatment Corporation (ARTC) is an outpatient opioid treatment program providing onsite primary medical care and HIV-related care for approximately 3,000 predominantly minority adults in New York City. There is substantial literature on the positive impact of co-location of substance abuse treatment and treatment of co-morbidities such as HIV disease and psychiatric illness. However, no literature looks at the impact of co-location of substance abuse treatment and treatment of coČ-morbidities such as hypertension and Type 2 diabetes mellitus, particularly for racial/ethnic minority substance abusers.

Description: We propose a retrospective chart review research study to assess this impact. The aims are to assess the impact of (1) substance abuse treatment and treatment for hypertension and Type 2 diabetes mellitus at ARTC on outcomes for substance abuse compared with patients in substance abuse treatment not treated for hypertension and Type 2 diabetes mellitus at ARTC; (2) substance abuse treatment and treatment of hypertension at ARTC on outcomes for hypertension compared with patients in substance abuse treatment not treated for hypertension at ARTC; and, (3) length of stay in substance abuse treatment on outcomes for hypertension and Type 2 diabetes mellitus treated at ARTC.

Lessons Learned: With an aging population of patients in opioid treatment programs, these co-morbidities take on added significance from an individual patient care and public health perspective.

Recommendations: Substance abuse treatment programs providing medical services can be laboratories for demonstrating whether the benefits of continuity of care extend beyond the general population

Learning Objectives:
Compare co-location of substance abuse and chronic disease treatment on substance abuse outcomes with treatment of substance abuse and chronic disease at separate locations. Compare co-location of substance abuse and chronic disease treatment on chronic disease outcomes with treatment of substance abuse and chronic disease at separate locations.

Keywords: Substance Abuse Treatment, Chronic Diseases

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am co-author of grant application
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.